FDA Inspection 1267125 — Nielsen Biosciences, Inc

Nielsen Biosciences, Inc — FEI 3010849583

The FDA completed an inspection of Nielsen Biosciences, Inc on Apr 17, 2025 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 17, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
San Diego, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113621 CFR 211.25(c)Inadequate number of personnel
135821 CFR 211.100(b)SOPs not followed / documented
194221 CFR 211.180(e)Records reviewed annually
202721 CFR 211.192Investigations of discrepancies, failures
908721 CFR 600.14(a)(1)Who must report - receiving information

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.